Orion Corporation has the pleasure to invite analysts, institutional investors and media to its Capital Market Day on Tuesday 26 May 2015. The event will be held at Finlandia Hall in Helsinki, Finland. The official program is from 9:00 a.m. to 1:00 p.m. EEST and will be followed by an informal lunch hosted by the Orion Corporation Executive Management.
An official invitation will be sent out in April. It will include more details regarding the day as well as information on how to register.
For further information, please contact
Communications Manager, IR and Financial Communications
tel. +358 10 426 2721
Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory for which Orion developes inhaled Easyhaler® pulmonary drugs.
Orion's net sales in 2014 amounted to EUR 1,015 million and the company had about 3,500 employees. Orion's A and B shares are listed on NASDAQ Helsinki.